Cart
sales@molnova.com
Parsaclisib
CAS No. 1426698-88-5
Parsaclisib ( INCB050465 )
Catalog No. M23581 CAS No. 1426698-88-5
Parsaclisib is a potent and selective inhibitor of PI3Kδ(IC50 of 1 nM at 1 mM ATP).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 290 | In Stock |
|
| 10MG | 470 | In Stock |
|
| 25MG | 763 | In Stock |
|
| 50MG | 1053 | In Stock |
|
| 100MG | 1422 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameParsaclisib
-
NoteResearch use only, not for human use.
-
Brief DescriptionParsaclisib is a potent and selective inhibitor of PI3Kδ(IC50 of 1 nM at 1 mM ATP).
-
DescriptionParsaclisib is a potent and selective inhibitor of PI3Kδ(IC50 of 1 nM at 1 mM ATP).
-
SynonymsINCB050465
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3Kδ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1426698-88-5
-
Formula Weight432.9
-
Molecular FormulaC20H22ClFN6O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:122 mg/mL?(281.83 mM;?Need ultrasonic)
-
SMILESCCOc(c([C@H](C)n1nc(C)c2c(N)ncnc12)c1)c([C@@H](C2)CNC2=O)c(F)c1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Niu Shin, et al. Abstract 2671: INCB050465, a novel PI3Kδ inhibitor, synergizes with PIM protein kinase inhibition to cause tumor regression in a model of DLBCL. Cancer Research. 2015, Aug. 75(15).
molnova catalog
related products
-
GSK-2636771
GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. Phase 1/2a.
-
P110δ-IN-1
ME-401 is an effective and selective inhibitor of P110δ (IC50: 8.4 nM).
-
Autophinib
Autophinib is a novel, potent autophagy inhibitor that inhibits autophagy induced by starvation (IC50=90 nM) or rapamycin (IC50=40 nM) by targeting the lipid kinase VPS34 (IC50=19 nM).
